Dariusz Pytel to DNA Repair
This is a "connection" page, showing publications Dariusz Pytel has written about DNA Repair.
Connection Strength
0.929
-
Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment. Curr Med Chem. 2019; 26(8):1425-1445.
Score: 0.159
-
Nucleotide Excision Repair Capacity and XPC and XPD Gene Polymorphism Modulate Colorectal Cancer Risk. Clin Colorectal Cancer. 2018 06; 17(2):e435-e441.
Score: 0.139
-
The role of base excision repair in pathogenesis of breast cancer in the Polish population. Mol Carcinog. 2016 12; 55(12):1899-1914.
Score: 0.128
-
The role of base excision repair in the development of primary open angle glaucoma in the Polish population. Mutat Res. 2015 Aug; 778:26-40.
Score: 0.124
-
BCR/ABL stimulates WRN to promote survival and genomic instability. Cancer Res. 2011 Feb 01; 71(3):842-51.
Score: 0.091
-
DNA damage and repair of head and neck cancer cells after radio- and chemotherapy. Z Naturforsch C J Biosci. 2009 Jul-Aug; 64(7-8):601-10.
Score: 0.082
-
[Uracil-DNA glycosylases]. Postepy Biochem. 2008; 54(4):362-70.
Score: 0.074
-
Imatinib (STI571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cells. Z Naturforsch C J Biosci. 2006 Nov-Dec; 61(11-12):896-902.
Score: 0.068
-
Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair. Mutat Res. 2006 Jan 31; 603(1):74-82.
Score: 0.065